UAE First Globally to Approve Innovative Treatment for Uncontrolled Hypertension
Abu dhabi: The Emirates Drug Establishment (EDE) has approved Baxfendy, an innovative medicine containing the active substance baxdrostat, developed by AstraZeneca. The treatment, available in 1 mg and 2 mg doses, is indicated as an add-on therapy alo…